Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Viviana Laredo"'
Publikováno v:
Frontiers in Nutrition, Vol 11 (2024)
Introduction and aimThe aim of this systematic review was to assess the role of vitamin C in the prevention of pancreatic cancer (PC).MethodsA comprehensive literature search was performed in PubMed, Embase and Web of Science up to August 2023, to id
Externí odkaz:
https://doaj.org/article/a4590a9282f244fcbd6804778bb07f6b
Autor:
Sandra García-Mateo, Samuel J. Martínez-Domínguez, Carla Jerusalén Gargallo-Puyuelo, María Teresa Arroyo Villarino, Viviana Laredo De La Torre, Beatriz Gallego, Erika Alfambra, Fernando Gomollón
Publikováno v:
Nutrients, Vol 15, Iss 18, p 3983 (2023)
Inflammatory bowel diseases (IBDs) are associated with an increased risk of metabolic comorbidities. There is a lack of data regarding the relationship between lifestyle and metabolic diseases in IBD patients. A cross-sectional study on consecutive I
Externí odkaz:
https://doaj.org/article/487d15d15c67419db0197855e2047b15
Autor:
Samuel J. Martínez-Domínguez, Sandra García-Mateo, Viviana Laredo, Carla J. Gargallo-Puyuelo, Beatriz Gallego Llera, Julia López de la Cruz, Fernando Gomollón
Publikováno v:
Cancers, Vol 15, Iss 13, p 3367 (2023)
The aim of the systematic review is to assess the prevalence and risk factors of liver fibrosis in patients with Inflammatory Bowel Disease (IBD) and Non-Alcoholic Fatty Liver Disease (NAFLD) and to discuss the role of liver fibrosis in the progressi
Externí odkaz:
https://doaj.org/article/c069e48972e24028804fbd0a7e786399
Autor:
Ana Gutiérrez, Pedro Zapater, Elena Ricart, María González-Vivó, Jordi Gordillo, David Olivares, Isabel Vera, Míriam Mañosa, Javier P. Gisbert, Mariam Aguas, Eugenia Sánchez-Rodríguez, Maia Bosca-Watts, Viviana Laredo, Blau Camps, Ignacio Marín-Jiménez, Yamile Zabana, María Dolores Martín-Arranz, Roser Muñoz, Mercè Navarro, Eva Sierra, Lucía Madero, Milagros Vela, José Lázaro Pérez-Calle, Empar Sainz, Xavier Calvet, Lara Arias, Victor Morales, Fernando Bermejo, Luis Fernández-Salazar, Manuel Van Domselaar, Luisa De Castro, Cristina Rodríguez, Carmen Muñoz-Villafranca, Rufo Lorente, Montserrat Rivero, Eva Iglesias, Belén Herreros, David Busquets, Joan Riera, María Pilar Martínez-Montiel, Marta Roldón, Oscar Roncero, Esther Hinojosa, Mónica Sierra, Jesús Barrio, Ruth De Francisco, José Huguet, Olga Merino, Daniel Carpio, Daniel Ginard, Fernando Muñoz, Marta Piqueras, Pedro Almela, Federico Argüelles-Arias, Guillermo Alcaín, Luis Bujanda, Noemí Manceñido, Alfredo J. Lucendo, Pilar Varela, Iago Rodríguez-Lago, Laura Ramos, Laura Sempere, Eva Sesé, Manuel Barreiro-de Acosta, Eugeni Domènech, Rubén Francés
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundPrevious studies comparing immigrant ethnic groups and native patients with IBD have yielded clinical and phenotypic differences. To date, no study has focused on the immigrant IBD population in Spain.MethodsProspective, observational, mult
Externí odkaz:
https://doaj.org/article/d35e6ff2cdf74ae5a842b5e0dd987f1c
Autor:
Viviana Laredo, Sandra García-Mateo, Samuel J. Martínez-Domínguez, Julia López de la Cruz, Carla J. Gargallo-Puyuelo, Fernando Gomollón
Publikováno v:
Cancers, Vol 15, Iss 3, p 871 (2023)
Chronic inflammation in patients with Inflammatory Bowel Disease (IBD) leads to an increased risk of colorectal cancer, small bowel cancer, intestinal lymphoma and cholangiocarcinoma. However, treatments for IBD have also been associated with an incr
Externí odkaz:
https://doaj.org/article/c7a2f2614d3049d684794ea45671c4a5
Publikováno v:
Antibiotics, Vol 11, Iss 12, p 1746 (2022)
Helicobacter pylori infection (H. pylori) is mainly managed at the primary care level. Our group previously performed a study demonstrating that providing specific counselling (SC) to primary care practitioners (PCPs) who requested a urea breath test
Externí odkaz:
https://doaj.org/article/9bb570a072b54809bc869e5977e4c123
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Thiopurines have been a cornerstone in the treatment of inflammatory bowel disease (IBD). Although they have been used for more than 50 years, there are still some unsolved issues about their efficacy and, also, some safety concerns, mainly the risk
Externí odkaz:
https://doaj.org/article/b42a6e764a434c0dba3ee53edcc5c37e
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 3, p 829 (2022)
The availability of biologic therapies in inflammatory bowel disease (IBD) is increasing significantly. This represents more options to treat patients, but also more difficulties in choosing the therapies, especially in the context of bio-naïve pati
Externí odkaz:
https://doaj.org/article/762b84041a174c63807a1e163c7a77b8
Autor:
Cristina Alonso-Madrigal, Manuela Dobón-Rebollo, Viviana Laredo-de-la-Torre, Luis Palomera-Bernal, Francisco-Agustín García-Gil
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 110, Iss 8, Pp 522-526 (2018)
RESUMEN Introducción: la infección por virus hepatitis C (VHC) ha sido causa de importante morbi-mortalidad en hemofilia, planteándose el trasplante hepático (TH) por cirrosis y/o carcinoma hepatocelular (CHC). Caso clínico: presentamos los caso
Externí odkaz:
https://doaj.org/article/0df4111cfa404fb4928dbfa084f787f7
Autor:
Viviana Laredo, Carlos Sostres, Sandra García, Patricia Carrera-Lasfuentes, Pablo Revilla-Marti, Ángel Lanas
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 5, p 1526 (2020)
The risk for gastrointestinal bleeding from dual antiplatelet therapy (DAPT) with new antiplatelets (prasugrel/ticagrelor) compared to clopidogrel is unclear. Aim: To determine the risk and type of major (gastrointestinal bleeding requiring hospitali
Externí odkaz:
https://doaj.org/article/3738dfcbcc174a64bf6705177f44d9f2